Real Endpoints plays 3rd party role introducing parties, helping craft structure, and will provide all analytics and financial reconciliation SAN DIEGO, WELLESLEY, Mass. and WESTPORT, Conn. — Illumina, Inc. and Harvard Pilgrim Health Care announced on February 1 a major new value-based contract (VBC) – one of the first of its kind between a […]
Patents in South Korea and Israel cover integration of an external DNA sequence into the chromosome of eukaryotic cells Merck continues to support research with genome editing under careful ethical and legal standards Merck to license its CRISPR-related patents to interested parties Darmstadt, Germany – Merck, a leading science and technology company and leader in genome editing, […]
Illumina and Genomics England partnership sequences 50,000 genomes The United Kingdom’s pioneering 100,000 Genomes Project has reached a major milestone by sequencing 50,000 genomes. Of those 50,000 genomes sequenced so far, 8,000 are for cancer patients and 42,000 for rare diseases. Breast, brain, colorectal, lung, prostate and renal are among those cancers to have […]
GenomeNext and Genomenon Partner to Speed Variant Curation for Whole Exome and Whole Genome Analysis ANN ARBOR, MI — GenomeNext, LLC announced today that it has embedded Genomenon’s Mastermind search results in its Olympus Platform to simplify and accelerate variant curation for genomic analysis. Efficacious variant interpretation is a critical but challenging requirement to translate genomics […]
— Patents in South Korea and Israel cover integration of an external DNA sequence into the chromosome of eukaryotic cells — MilliporeSigma continues to support research with genome editing under careful ethical and legal standards — MilliporeSigma to license CRISPR-related patents to interested parties BURLINGTON, Mass. — MilliporeSigma, a leader in genome editing, today announced that the Korean Intellectual Property Office […]
A highly versatile and customizable automation solution for budget and space constrained laboratories RADNOR, Pennsylvania — VWR, acquired by Avantor in 2017 as a wholly-owned subsidiary and leading global provider of product and service solutions to laboratory and production customers, announced today it has reached an agreement with Hamilton Bonaduz AG, a leading provider in the design […]
The U.S. International Trade Commission (USITC) has voted to institute an investigation of certain microfluidic systems and components thereof and products containing same. The products at issue in the investigation include microfluidic cartridges, reagents, and devices for preparing samples for sequencing. The investigation is based on a complaint filed by 10X Genomics, Inc., of Pleasanton, […]
SAN FRANCISCO, Calif. – Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced the commercial availability of several new products to enhance next-generation sequencing including its Twist Human Core Exome Kit, an innovative and comprehensive library preparation and target enrichment kit, and its Custom Panels offering, that […]
Test rapidly detects 47 antimicrobial resistance markers directly from urine and bacterial isolates GAITHERSBURG, Md. — OpGen, Inc. (NASDAQ:OPGN) announced today that it has entered into a global supply agreement to use Thermo Fisher Scientific’s real-time PCR technology in the company’s Acuitas® AMR Gene Panel Tests. The first test, the Research Use Only (RUO) AMR […]
Truth-set NGS reference materials that broaden capabilities for tumor profiling assay validation and QC MILFORD, Mass. — SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories, is expanding what is already the most comprehensive suite of clinical genomics development, validation, and QC tools with the launch of the SeraseqTM Breast CNV and Seraseq™ Lung […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
